Lack of Access to Abortion Has Had a Negative Impact on Cancer Care
Since the US Supreme Court overturned Roe v Wade last year, restrictions on access to abortion have had a negative impact on cancer care.
Hematologic Cancer
HEMATOLOGIC CANCER ADVISOR
FEATURED CONTENT
-
-
Ibrutinib No Longer Approved for MCL, MZL: How This Change Will Affect Patients
The withdrawn approvals of ibrutinib for relapsed/refractory MCL and MZL are likely to have a limited impact on patients, experts say. -
ART and Pediatric Cancer: Risk May Vary by Method Used, Cancer Type
Research has suggested that ART may increase the risk of pediatric cancers, but studies have shown conflicting results, and questions remain. -
Preventing and Treating COVID-19 in Cancer Patients: Challenges in the Omicron Era
Methods to prevent and treat COVID-19 in cancer patients have had to evolve alongside the SARS-CoV-2 virus. -
Sexual Health and Cancer: What Providers Need to Know
Sexual dysfunction may be common in cancer patients and survivors, but their sexual health is often overlooked.
HEMATOLOGIC CANCER NEWS
Pirtobrutinib Produces Durable Responses in Relapsed/Refractory MCL
Childhood Cancer Survivors Have Higher Risk of Late Surgical Interventions
AYA Cancer Survivors Have Increased Risk of HPV-Linked Subsequent Cancer
Epkinly Approved for Relapsed, Refractory Diffuse Large B-Cell Lymphoma
Educational Program Improves Communication About Cancer Clinical Trials
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Hematologic Cancers
Loading... 
Loading...